2-Methyl-3-(4-methoxyphenyl)-N-propargyl-6-aminoquinoxaline

ID: ALA4555367

PubChem CID: 88990365

Max Phase: Preclinical

Molecular Formula: C19H17N3O

Molecular Weight: 303.37

Molecule Type: Unknown

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  C#CCNc1ccc2nc(C)c(-c3ccc(OC)cc3)nc2c1

Standard InChI:  InChI=1S/C19H17N3O/c1-4-11-20-15-7-10-17-18(12-15)22-19(13(2)21-17)14-5-8-16(23-3)9-6-14/h1,5-10,12,20H,11H2,2-3H3

Standard InChI Key:  JROUHQNYKBDCDK-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 23 25  0  0  0  0  0  0  0  0999 V2000
   12.2162  -11.4304    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   12.9253  -11.0218    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.9253  -10.2046    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.2162   -9.7960    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   11.5071  -10.2046    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.8021   -9.7960    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.0931  -10.2046    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.0931  -11.0218    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.8021  -11.4304    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.5071  -11.0218    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.3840   -9.7960    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    8.6790  -10.2046    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.9699   -9.7960    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.2608   -9.3874    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.6303   -9.7960    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.3393  -10.2046    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.0484   -9.7960    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.0484   -8.9788    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.3393   -8.5702    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.6302   -8.9788    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.7534   -8.5702    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   16.4625   -8.9788    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.6303  -11.4304    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
  1 10  1  0
  5 10  1  0
  7 11  1  0
 12 13  1  0
 13 14  3  0
 11 12  1  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
 15 20  2  0
 21 22  1  0
 18 21  1  0
  3 15  1  0
  2 23  1  0
M  END

Associated Targets(non-human)

Astrocyte (64 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 303.37Molecular Weight (Monoisotopic): 303.1372AlogP: 3.66#Rotatable Bonds: 4
Polar Surface Area: 47.04Molecular Species: NEUTRALHBA: 4HBD: 1
#RO5 Violations: HBA (Lipinski): 4HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 3.10CX LogP: 3.01CX LogD: 3.01
Aromatic Rings: 3Heavy Atoms: 23QED Weighted: 0.75Np Likeness Score: -1.23

References

1. Le Douaron G, Ferrié L, Sepulveda-Diaz JE, Amar M, Harfouche A, Séon-Méniel B, Raisman-Vozari R, Michel PP, Figadère B..  (2016)  New 6-Aminoquinoxaline Derivatives with Neuroprotective Effect on Dopaminergic Neurons in Cellular and Animal Parkinson Disease Models.,  59  (13): [PMID:27341519] [10.1021/acs.jmedchem.6b00297]

Source